{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:15:10Z","timestamp":1786119310672,"version":"build-2736575974"},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1097\/mbc.0b013e32832ff577","type":"journal-article","created":{"date-parts":[[2009,9,29]],"date-time":"2009-09-29T03:14:48Z","timestamp":1254194088000},"page":"583-589","source":"Crossref","is-referenced-by-count":26,"title":["Treatment of deep venous thrombosis with low molecular weight heparin in pediatric cancer patients: safety and efficacy"],"prefix":"10.1097","volume":"20","author":[{"given":"Katerina","family":"Tousovska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ondrej","family":"Zapletal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jarmila","family":"Skotakova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"Bukac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaroslav","family":"Sterba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-16-20210203","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1055\/s-2007-976177","article-title":"Thromboembolic complications in pediatric hematology malignancies","volume":"33","author":"Athale","year":"2007","journal-title":"Sem Thromb Hemost"},{"key":"R2-16-20210203","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1378\/chest.126.3_suppl.645S","article-title":"Antithrombotic therapy in children: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy","volume":"126","author":"Monagle","year":"2004","journal-title":"Chest"},{"key":"R3-16-20210203","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1182\/blood.V83.5.1251.1251","article-title":"Venous Thrombembolic Complications (VTE) in Children: First Analyses of the Canadian Registry of VTE","volume":"83","author":"Andrew","year":"1994","journal-title":"Blood"},{"key":"R4-16-20210203","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1182\/blood-2006-04-015511","article-title":"Thrombotic complications in childhood acute lymphoblastic leukemia: a meta-analysis of 17 prospective studies comprising 1752 pediatric patients","volume":"108","author":"Caruso","year":"2006","journal-title":"Blood"},{"key":"R5-16-20210203","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1055\/s-0037-1616244","article-title":"Thromboembolism in newborns, infants and children","volume":"86","author":"Nowak-G\u00f6ttl","year":"2001","journal-title":"Thromb Haemost"},{"key":"R6-16-20210203","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.thromres.2003.10.013","article-title":"Thrombosis in children with acute lymphoblastic leukaemia. Part I: Epidemiology of thrombosis in children with acute lymphoblastic leukemia","volume":"111","author":"Athale","year":"2003","journal-title":"Thromb Res"},{"key":"R7-16-20210203","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1160\/TH02-11-0283","article-title":"Trend to efficacy and safety using antithrombin concentrate in prevention of thrombosis in children receiving L-asparaginase for acute lymphoblastic leukaemia","volume":"90","author":"Mitchell","year":"2003","journal-title":"Thromb Haemost"},{"key":"R8-16-20210203","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/pbc.21047","article-title":"Thrombembolism in children with sarcoma","volume":"49","author":"Athale","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"R9-16-20210203","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.mop.0000193270.09001.ea","article-title":"Thrombosis in children with malignancy","volume":"18","author":"Bajzar","year":"2006","journal-title":"Curr Opin Pediatr"},{"key":"R10-16-20210203","first-page":"453","article-title":"Venous thromboembolism and cancer: new insights and therapy.","volume":"450-","author":"Lee","year":"2005","journal-title":"Hematology"},{"key":"R11-16-20210203","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1160\/TH04-04-0207","article-title":"Systemic thromboembolism in children. Data from the I-800-NO CLOTS consultation Service","volume":"92","author":"Kuhle","year":"2004","journal-title":"Thromb Haemost"},{"key":"R12-16-20210203","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0049-3848(01)00286-9","article-title":"Thrombotic events revisited in children with acute lymphoblastic leukaemia. Impact of concomitant Escherichia coli asparaginase\/prednisone administration","volume":"103","author":"Nowak-G\u00f6ttl","year":"2002","journal-title":"Thromb Res"},{"key":"R13-16-20210203","first-page":"461","article-title":"Acquired risk factors for venous thromboembolism in medical patients.","volume":"458-","author":"Prandoni","year":"2005","journal-title":"Hematology"},{"key":"R14-16-20210203","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1365-2141.2006.06200.x","article-title":"The postthrombotic syndrome: progress and pitfalls","volume":"134","author":"Kahn","year":"2006","journal-title":"Br J Haematol"},{"key":"R15-16-20210203","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1182\/blood-2006-12-061234","article-title":"A thrombolytic regimen for high-risk deep venous thrombosis may substantially reduce the risk of postthrombotic syndrome in children","volume":"110","author":"Goldenberg","year":"2007","journal-title":"Blood"},{"key":"R16-16-20210203","first-page":"515","article-title":"Normalization rates of compression ultrasonography in patients with a first episode of deep vein thrombosis of the lower limbs: association with recurrence and new thrombosis","volume":"87","author":"Beltrametti","year":"2002","journal-title":"Haematologica"},{"key":"R17-16-20210203","doi-asserted-by":"crossref","first-page":"955","DOI":"10.7326\/0003-4819-137-12-200212170-00008","article-title":"Residual vein thrombosis as a predictive factor of recurrent venous thromboembolism","volume":"137","author":"Prandoni","year":"2002","journal-title":"Ann Inter Med"},{"key":"R18-16-20210203","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1056\/NEJMoa040161","article-title":"Elevated plasma factor VIII and D-dimer levels as predictors of poor outcomes of thrombosis in children","volume":"351","author":"Goldenberg","year":"2004","journal-title":"N Engl J Med"},{"key":"R19-16-20210203","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.thromres.2003.09.008","article-title":"A cross sectional study evaluating postthrombotic syndrome in children","volume":"111","author":"Kuhle","year":"2003","journal-title":"Thromb Res"},{"key":"R20-16-20210203","first-page":"1701","article-title":"Long-term safety and efficacy on childhood venous thrombosis treated with a low molecular Wight heparin: an open-label pilot study of once-daily versus twice daily enoxaparin administration","volume":"91","author":"Schobess","year":"2006","journal-title":"Haematologica"},{"key":"R21-16-20210203","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/00043426-200103000-00015","article-title":"Low molecular-weight heparin therapy in children","volume":"23","author":"Massicotte","year":"2001","journal-title":"J Pediatr Hematol Oncol"},{"key":"R22-16-20210203","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1055\/s-2001-17961","article-title":"How and when to monitor a patient treated with low molecular weight heparin","volume":"27","author":"Boneu","year":"2001","journal-title":"Sem Thromb Hemost"},{"key":"R23-16-20210203","doi-asserted-by":"crossref","first-page":"333","DOI":"10.2165\/00002018-200528040-00005","article-title":"Safety profile of different low-molecular weight heparins used at therapeutic dose","volume":"4","author":"Gouin-Thibault","year":"2005","journal-title":"Drug Safety"},{"key":"R24-16-20210203","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1182\/blood-2004-11-4211","article-title":"How I treat venous thrombosis in children","volume":"107","author":"Manco-Johnson","year":"2006","journal-title":"Blood"},{"issue":"Suppl 3","key":"R25-16-20210203","doi-asserted-by":"crossref","first-page":"S134","DOI":"10.1007\/PL00014339","article-title":"The low molecular weight heparin dalteparin for prophylaxis and therapy of thrombosis in childhood: a report on 48 cases","volume":"158","author":"Nohe","year":"1999","journal-title":"Eur J Pediatr"},{"key":"R26-16-20210203","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1159\/000090940","article-title":"Long-term treatment of thrombosis with enoxaparin in pediatric and adolescent patients","volume":"115","author":"Merkel","year":"2006","journal-title":"Acta Haematol"},{"key":"R27-16-20210203","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/00007691-200406000-00015","article-title":"Effect of renal function on the pharmacokinetics of enoxaparin and consequences on dose adjustment","volume":"26","author":"Hulot","year":"2004","journal-title":"Drug Monit"},{"key":"R28-16-20210203","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1538-7836.2004.00532.x","article-title":"Natural history of arterial and venous thrombosis in children treated with low molecular weight heparin: a longitudinal study by ultrasound","volume":"2","author":"Revel-Vilk","year":"2003","journal-title":"J Thromb Haemost"},{"key":"R29-16-20210203","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1177\/1076029606298989","article-title":"Treatment of deep vein thrombosis with enoxaparin in pediatric cancer patients receiving chemotherapy","volume":"13","author":"Stine","year":"2002","journal-title":"Clin Appl Thromb Haemost"},{"key":"R30-16-20210203","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/00001721-200107000-00005","article-title":"Prophylactic therapy with enoxaparin during L-asparaginase treatment in children with acute lymphoblastic leukaemia","volume":"12","author":"Elhasid","year":"2001","journal-title":"Blood Coagul Fibrinolysis"},{"key":"R31-16-20210203","doi-asserted-by":"crossref","first-page":"4027","DOI":"10.1182\/blood-2005-04-1508","article-title":"How I treat venous thromboembolism in patients with cancer","volume":"106","author":"Prandoni","year":"2005","journal-title":"Blood"},{"key":"R32-16-20210203","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/sj.bmt.1704952","article-title":"Safety of low-dose low-molecular weight heparins in thrombocytopenic stem cell transplantation patients: a case series and review of the literature","volume":"35","author":"Ibrahim","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"R33-16-20210203","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2174\/157489007779606077","article-title":"A practical approach to diagnosis and treatment of symptomatic thromboembolic events in children with acute lymphoblastic leukemia: recommendations of the \u2018coagulation defects\u2019 AEIOP Working Group","volume":"2","author":"Giordano","year":"2007","journal-title":"Recent Patents Cardiovasc Drug Discov"},{"key":"R34-16-20210203","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1055\/s-2007-976179","article-title":"Management of thromboembolism in hematologic malignancies","volume":"33","author":"Chong","year":"2007","journal-title":"Sem Thromb Hemost"},{"key":"R35-16-20210203","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3324\/haematol.11458","article-title":"Clinical characteristics and management of cancer-associated acute venous thromboembolism: findings from the MASTER registry","volume":"93","author":"Imberti","year":"2008","journal-title":"Haematologica"},{"key":"R36-16-20210203","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1080\/08035250600729092","article-title":"Low dose warfarin for the prevention of central line-associated thrombosis in children with malignancies: a randomized, controlled study","volume":"95","author":"Ruud","year":"2006","journal-title":"Acta Paediatr"},{"key":"R37-16-20210203","first-page":"15","article-title":"Arguments against monitoring levels of anti-factor Xa in conjunction with low-molecular-weight heparin therapy","volume":"55","author":"Rosenbloom","year":"2002","journal-title":"Can J Hosp Pharm"},{"key":"R38-16-20210203","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/01.mph.0000139453.22338.d9","article-title":"An assessment of published pediatric dosage guidelines for enoxaparin. A retrospective review","volume":"26","author":"Ho","year":"2004","journal-title":"J Pediatr Hematol Oncol"},{"key":"R39-16-20210203","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0022-3476(00)90005-2","article-title":"The use of low molecular weight heparin in pediatric patients: a prospective cohort study","volume":"136","author":"Dix","year":"2000","journal-title":"J Pediatr"},{"key":"R40-16-20210203","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1055\/s-0038-1642507","article-title":"Adjusted versus fixed doses of the low-molecular-weight heparin Fragmin in the treatment of deep vein thrombosis. Fragmin Study Group","volume":"71","author":"Alhenc-Gelas","year":"1994","journal-title":"Thromb Haemost"},{"key":"R41-16-20210203","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1182\/blood.V97.4.858","article-title":"Risk of recurrent venous thrombosis in children with combined prothrombotic risk factors","volume":"87","author":"Nowak-G\u00f6ttl","year":"2001","journal-title":"Blood"}],"container-title":["Blood Coagulation & Fibrinolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MBC.0b013e32832ff577","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:59:45Z","timestamp":1786039185000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001721-200910000-00016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":41,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/mbc.0b013e32832ff577","relation":{},"ISSN":["0957-5235"],"issn-type":[{"value":"0957-5235","type":"print"}],"subject":[],"published":{"date-parts":[[2009,10]]}}}